Japan News
-
Sosei Heptares teams up with Genentech for multi-target R&D
Japan | News | 0 Comment | 17 Jul, 2019
Japan headquartered Sosei Group Corporation has entered into a multi-target research collaboration and license agreement with Genentech, a member of the Roche Group, to discover and develop...Read more
-
Kaneka launches takeover bid for 100% of AB-Biotics
Japan | News | 0 Comment | 16 Jul, 2019
AB-Biotics announced that Kaneka Europe Holding Company has launched a voluntary takeover bid for 100% of the share capital of the company excluding the shares it already possesses, consequ...Read more
-
Eisai Centre for G2D2 commences operation towards dementia treatment
Japan | News | 0 Comment | 16 Jul, 2019
Japan based pharmaceutical firm Eisai Co., Ltd. has announced that the Eisai Center for Genetics Guided Dementia Discovery (G2D2), a new exploratory research facility in Cambridge, Massachu...Read more
-
Japanese researchers use AI to design novel endoscopy
Japan | News | 0 Comment | 15 Jul, 2019
Researchers at Okayama University have developed an early gastric cancer endoscopic diagnosis system using artificial intelligence (AI). The details were presented at the Congress of the Ja...Read more
-
PHC launches medical integrated chart system for doctors
Japan | News | 0 Comment | 12 Jul, 2019
PHC is launching Medicom-HRf, an integrated medical chart system for medical clinics, with the aim to strengthen communication with patients. In recent years, the increasing number of dis...Read more
-
Japan | News | 0 Comment | 10 Jul, 2019
CMIC Group, a pioneer and a leading CRO (Contract Research Organizations) in Japan, announced on 10 July 2019, that the company joined Align Clinical CRO, a life sciences industry stan...Read more
-
Eisai collaborates with University of Dundee for cancer drug discovery
Japan | News | 0 Comment | 09 Jul, 2019
Japanese pharmaceutical firm Eisai Co.,Ltd. has announced that it has entered into a collaboration research agreement with the University of Dundee in Scotland, UK, regarding Proteolysis Ta...Read more
-
Takeda announces results from Phase IIIb/IV clinical trial for ADYNOVATE
Japan | News | 0 Comment | 08 Jul, 2019
Takeda, an R&D-driven, global biopharmaceutical company with a leadership position in rare diseases has announced updated results from its phase IIIb/IV clinical trial for ADYNOVATE&nbs...Read more
-
21st Interphex Week Japan: Making the event as one of the largest pharma industry events in Asia
Japan | Opinion | By Ankit Kankar | 0 Comment | 05 Jul, 2019
5 july 2019 , Tokyo. In Speaking with an official show director of Reed Exhibition , An official summarised an event as below : Close to 45,000 appx individuals and 1280 Appx Exhibi...Read more
-
21st Interphex Week Japan concludes in Tokyo
Japan | News | By Ankit Kankar | 0 Comment | 05 Jul, 2019
5 July 2019 , Tokyo . Interphex Japan concludes in Tokyo 45,000 appx Visitors from around the world including all concurrent shows . 1280 Appx Exhibitors from 34 countries of world. 300...Read more
-
More than 600 Pharma / Cosmetics / Chemical & Biotech executives attended Reed VIP Reception Party
Japan | News | By Ankit Kankar | 0 Comment | 04 Jul, 2019
04 July 2019 , Tokyo . The reception was held as a networking event that is greatly appreciated by attendees for gaining pathways to Japan and the world . VIP Attendes were ...Read more
-
INTERPHEX Japan puts up an impressive show
Japan | News | By Ankit Kankar | 0 Comment | 04 Jul, 2019
INTERPHEX JAPAN is Japan's largest and Asia's leading exhibition for pharmaceutical manufacturing and packaging technologies. Including concurrent pharma technology exhibitions, 1,280 exhib...Read more
-
Miraca and 7SBio announce strategic investment
Japan | News | 0 Comment | 04 Jul, 2019
Seventh Sense Biosystems, Inc. (7SBio), makers of TAP™, the world's first push-button blood collection device, and Miraca Holdings Inc. or Miraca ($MRCHF), the lar...Read more
-
Century Therapeutics launches with $250M financing for iPSC allogeneic cell therapy platform
Japan | News | 0 Comment | 02 Jul, 2019
Century Therapeutics, which was created by Versant Ventures as part of the firm’s core strategy to launch innovative biotech companies, emerged from stealth mode recently with USD 250...Read more
-
Takeda sells Xiidra to Novartis
Japan | News | 0 Comment | 02 Jul, 2019
Takeda has announced the completion of its sale of its Xiidra (lifitegrast ophthalmic solution) 5% product to Novartis for $3.4 billion upfront in cash and up to an additional $1.9 billion ...Read more
-
PHC Holdings completes acquisition deal with Thermo Fisher
Japan | News | 0 Comment | 02 Jul, 2019
Japan headquartered PHC Holdings Corporation has announced the completion of its acquisition of Anatomical Pathology business of Thermo Fisher Scientific for approximately US$1.14 billion. ...Read more
-
PeptiDream announces new PDC collaboration with Novartis
Japan | News | 0 Comment | 28 Jun, 2019
PeptiDream Inc., a public Kanagawa-based biopharmaceutical company, on 27 June 2019, announced a new Peptide Drug Conjugate “PDC” collaboration agreement with Swiss-based Novart...Read more
-
Takeda selects new partnerships for annual CSR programme
Japan | News | 0 Comment | 26 Jun, 2019
Japanese company Takeda Pharmaceutical has announced the addition of five partners to its Global CSR programme for 2019, which contributes to the long-term health of people through disease ...Read more
